DiaMedica Therapeutics
DMAC
DMAC
98 hedge funds and large institutions have $79.2M invested in DiaMedica Therapeutics in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.68% less ownership
Funds ownership: 23.15% → 22.46% (-0.68%)
18% less capital invested
Capital invested by funds: $96M → $79.2M (-$16.8M)
Holders
98
Holding in Top 10
1
Calls
$194K
Puts
$142K
Top Buyers
| 1 | +$1.32M | |
| 2 | +$576K | |
| 3 | +$476K | |
| 4 |
CI
Corient IA
Miami,
Florida
|
+$475K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$441K |
Top Sellers
| 1 | -$3.5M | |
| 2 | -$825K | |
| 3 | -$662K | |
| 4 |
Goldman Sachs
New York
|
-$555K |
| 5 |
Barclays
London,
United Kingdom
|
-$368K |
